Jonathan Robinson
Optometrist · Rock Hill, SCNPI 1083874036
Payments from drug & device makers
Across 39 payments — averaging $23.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$227
- Johnson & Johnson Surgical Vision, Inc.$82
- AbbVie$79
- Alcon$62
- Harrow Eye, LLC$58
- Bausch & Lomb Americas Inc.$52
- plus $345 from 13 others
What the payments were for
- Food & beverage$80289%
- Other$10311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 9 | $227 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $82 |
| AbbVie(2 entities) | 5 | $79 |
| Alcon | 3 | $62 |
| Harrow Eye, LLC | 2 | $58 |
| Bausch & Lomb Americas Inc. | 3 | $52 |
| Welch Allyn | 1 | $51 |
| Baxter Healthcare | 1 | $51 |
| Aerie Pharmaceuticals, Inc. | 2 | $41 |
| Rxsight Inc | 1 | $24 |
| Sight Sciences, Inc. | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $22 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $20 |
| Glaukos Corporation | 1 | $19 |
| Novartis | 1 | $18 |
| Maculogix, Inc. | 1 | $16 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$905 in reported general payments places this provider in the 50th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 174 | $1,936 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 55 | $652 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $319 |
| Brimonidine Tartrate | 26 | $267 |
| Timolol Maleate | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Rock Hill
- Scott OliverRock Hill$16K
- David OliverRock Hill$6K
- Brandi M SalazarRock Hill$5K
- Patrick VollmerColumbia$1.6M
- Elliott KellerBoiling Springs$276K
- William SpearmanPickens$104K
- Thomas WeshefskyMyrtle Beach$77K
- Duc TranColumbia$57K
- Richard BedellCharleston$55K
- William ColemanEasley$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.